GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Price-to-Owner-Earnings

Fagron (Fagron) Price-to-Owner-Earnings : 16.60 (As of May. 23, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Price-to-Owner-Earnings?

As of today (2024-05-23), Fagron's share price is $18.58929. Fagron's Owner Earnings per Share (TTM) ended in Dec. 2023 was $1.12. It's Price-to-Owner-Earnings for today is 16.60.


The historical rank and industry rank for Fagron's Price-to-Owner-Earnings or its related term are showing as below:

ARSUF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.25   Med: 22.72   Max: 90.22
Current: 16.58

During the past 13 years, the highest Price-to-Owner-Earnings of Fagron was 90.22. The lowest was 11.25. And the median was 22.72.


ARSUF's Price-to-Owner-Earnings is ranked better than
69.76% of 420 companies
in the Drug Manufacturers industry
Industry Median: 27.395 vs ARSUF: 16.58

As of today (2024-05-23), Fagron's share price is $18.58929. Fagron's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.06. Therefore, Fagron's PE Ratio for today is 17.62.

As of today (2024-05-23), Fagron's share price is $18.58929. Fagron's EPS without NRI for the trailing twelve months (TTM) ended in was $1.06. Therefore, Fagron's PE Ratio without NRI for today is 17.62.

During the past 13 years, Fagron's highest PE Ratio without NRI was 30.44. The lowest was 4.14. And the median was 21.60.


Fagron Price-to-Owner-Earnings Historical Data

The historical data trend for Fagron's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Price-to-Owner-Earnings Chart

Fagron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.90 20.78 20.19 11.34 14.67

Fagron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.19 - 11.34 - 14.67

Competitive Comparison of Fagron's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Fagron's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fagron's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fagron's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Fagron's Price-to-Owner-Earnings falls into.



Fagron Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Fagron's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=18.58929/1.12
=16.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fagron  (OTCPK:ARSUF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Fagron Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Fagron's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Fagron (Fagron) Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies which are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America and Fagron Latin America. Majority of its revenue comes from Fagron EMEA.

Fagron (Fagron) Headlines

From GuruFocus

Q2 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Full Year 2019 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2022 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2019 Fagron NV Corporate Sales Call Transcript

By GuruFocus Research 02-12-2024

Q3 2023 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q1 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2023 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Fagron NV At Capital Markets Day Transcript

By GuruFocus Research 02-12-2024

Q4 2021 Fagron NV Earnings Presentation Transcript

By GuruFocus Research 02-12-2024